Literature DB >> 12529398

Liver-specific reactivation of the inactivated Hnf-1alpha gene: elimination of liver dysfunction to establish a mouse MODY3 model.

Ying-Hue Lee1, Mark A Magnuson, Vijayakumar Muppala, Shih-Shun Chen.   

Abstract

Mice deficient in hepatocyte nuclear factor 1 alpha (HNF-1alpha) develop dwarfism, liver dysfunction, and type 2 diabetes mellitus. Liver dysfunction in HNF-1alpha-null mice includes severe hepatic glycogen accumulation and dyslipidemia. The liver dysfunction may appear as soon as 2 weeks after birth. Since the HNF-1alpha-null mice become diabetic 2 weeks after birth, the early onset of the liver dysfunction is unlikely to be due to the diabetic status of the mice. More likely, it is due directly to the deficiency of HNF-1alpha in liver. Although the HNF-1alpha-null mice have an average life span of 1 year, the severe liver phenotype has thwarted attempts to study the pathogenesis of maturity-onset diabetes of the young type 3 (MODY3) and to examine therapeutic strategies for diabetes prevention and treatment in these mice. To circumvent this problem, we have generated a new Hnf-1alpha mutant mouse line, Hnf-1alpha(kin/kin), using gene targeting to inactivate the Hnf-1alpha gene and at the same time, to incorporate the Cre-loxP DNA recombination system into the locus for later revival of the Hnf-1alpha gene in tissues by tissue-specifically expressed Cre recombinase. The Hnf-1alpha(kin/kin) mice in which the expression of HNF-1alpha was inactivated in germ line cells were indistinguishable from the HNF-1alpha-null mice with regard to both the diabetes and liver phenotypes. Intriguingly, when the inactivated Hnf-1alpha gene was revived in liver (hepatic Hnf-1alpha revived) by the Cre recombinase driven by an albumin promoter, the Hnf-1alpha(kin/kin) mice, although severely diabetic, grew normally and did not develop any of the liver dysfunctions. In addition, we showed that the expression of numerous genes in pancreas, including a marker gene for pancreas injury, was affected by liver dysfunction but not by the deficiency of HNF-1alpha in pancreas. Thus, our hepatic-Hnf-1alpha-revived mice may serve as a useful mouse model to study the human MODY3 disorder.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529398      PMCID: PMC140695          DOI: 10.1128/MCB.23.3.923-932.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  29 in total

1.  The determination of glycogen in liver and muscle by use of anthrone reagent.

Authors:  N V CARROLL; R W LONGLEY; J H ROE
Journal:  J Biol Chem       Date:  1956-06       Impact factor: 5.157

2.  Loss of BETA2/NeuroD leads to malformation of the dentate gyrus and epilepsy.

Authors:  M Liu; S J Pleasure; A E Collins; J L Noebels; F J Naya; M J Tsai; D H Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.

Authors:  C Postic; M Shiota; K D Niswender; T L Jetton; Y Chen; J M Moates; K D Shelton; J Lindner; A D Cherrington; M A Magnuson
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

Review 4.  A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus.

Authors:  J F Habener; D A Stoffers
Journal:  Proc Assoc Am Physicians       Date:  1998 Jan-Feb

Review 5.  Cell-specific roles of glucokinase in glucose homeostasis.

Authors:  C Postic; M Shiota; M A Magnuson
Journal:  Recent Prog Horm Res       Date:  2001

6.  The role of HNF-1alpha in controlling hepatic catalase activity.

Authors:  V Muppala; C S Lin; Y H Lee
Journal:  Mol Pharmacol       Date:  2000-01       Impact factor: 4.436

7.  Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.

Authors:  M Pontoglio; S Sreenan; M Roe; W Pugh; D Ostrega; A Doyen; A J Pick; A Baldwin; G Velho; P Froguel; M Levisetti; S Bonner-Weir; G I Bell; M Yaniv; K S Polonsky
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

8.  Defective pancreatic beta-cell glycolytic signaling in hepatocyte nuclear factor-1alpha-deficient mice.

Authors:  I D Dukes; S Sreenan; M W Roe; M Levisetti; Y P Zhou; D Ostrega; G I Bell; M Pontoglio; M Yaniv; L Philipson; K S Polonsky
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

9.  Comparison of reg I and reg III levels during acute pancreatitis in the rat.

Authors:  M E Zenilman; D Tuchman; Q Zheng; J Levine; H Delany
Journal:  Ann Surg       Date:  2000-11       Impact factor: 12.969

Review 10.  New insights into the role and mechanism of glycogen synthase activation by insulin.

Authors:  J C Lawrence; P J Roach
Journal:  Diabetes       Date:  1997-04       Impact factor: 9.461

View more
  5 in total

1.  Differential transcriptional characteristics of small and large biliary epithelial cells derived from small and large bile ducts.

Authors:  S Glaser; M Wang; Y Ueno; J Venter; K Wang; H Chen; G Alpini; A Holterman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-24       Impact factor: 4.052

2.  Organ-specific roles of CYP1A1 during detoxication of dietary benzo[a]pyrene.

Authors:  Zhanquan Shi; Nadine Dragin; Marina Gálvez-Peralta; Lucia F Jorge-Nebert; Marian L Miller; Bin Wang; Daniel W Nebert
Journal:  Mol Pharmacol       Date:  2010-04-06       Impact factor: 4.436

3.  Hepatocyte nuclear factor-1alpha regulates glucocorticoid receptor expression to control postnatal body growth.

Authors:  Wan-Yi Lin; Yu-Jie Hu; Ying-Hue Lee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-06-26       Impact factor: 4.052

4.  EZH2 RIP-seq Identifies Tissue-specific Long Non-coding RNAs.

Authors:  Yan Wang; Yinping Xie; Lili Li; Yuan He; Di Zheng; Pengcheng Yu; Ling Yu; Lixu Tang; Yibin Wang; Zhihua Wang
Journal:  Curr Gene Ther       Date:  2018       Impact factor: 4.391

5.  Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3.

Authors:  Mengdie Hu; Xiuting Huang; Xueyao Han; Linong Ji
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-02       Impact factor: 3.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.